| Literature DB >> 24843127 |
Chong Wee Liew1, Anke Assmann2, Andrew T Templin3, Jeffrey C Raum4, Kathryn L Lipson5, Sindhu Rajan6, Guifen Qiang7, Jiang Hu2, Dan Kawamori2, Iris Lindberg8, Louis H Philipson6, Nahum Sonenberg9, Allison B Goldfine2, Doris A Stoffers4, Raghavendra G Mirmira3, Fumihiko Urano10, Rohit N Kulkarni11.
Abstract
Insulin resistance, hyperinsulinemia, and hyperproinsulinemia occur early in the pathogenesis of type 2 diabetes (T2D). Elevated levels of proinsulin and proinsulin intermediates are markers of β-cell dysfunction and are strongly associated with development of T2D in humans. However, the mechanism(s) underlying β-cell dysfunction leading to hyperproinsulinemia is poorly understood. Here, we show that disruption of insulin receptor (IR) expression in β cells has a direct impact on the expression of the convertase enzyme carboxypeptidase E (CPE) by inhibition of the eukaryotic translation initiation factor 4 gamma 1 translation initiation complex scaffolding protein that is mediated by the key transcription factors pancreatic and duodenal homeobox 1 and sterol regulatory element-binding protein 1, together leading to poor proinsulin processing. Reexpression of IR or restoring CPE expression each independently reverses the phenotype. Our results reveal the identity of key players that establish a previously unknown link between insulin signaling, translation initiation, and proinsulin processing, and provide previously unidentified mechanistic insight into the development of hyperproinsulinemia in insulin-resistant states.Entities:
Keywords: ER stress; GWAS; bIRKO; prohormone
Mesh:
Substances:
Year: 2014 PMID: 24843127 PMCID: PMC4050564 DOI: 10.1073/pnas.1323066111
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205